Rheonix

United States
Boscawen, New Hampshire, United States, 14850

Company profile

Rheonix company profile

Rheonix, Inc. operates as a biomedical device company. Its products include CARD (Chemistry And Reagent Device) system to miniaturize and automate new and existing assays in multiple fields. Its products and technology are used in human/veterinary in vitro diagnostics, food/water testing, SNP analysis for personalized medicine applications, homeland security/defense applications, process control and final product QC, and tissue culture analysis in a research or production setting. Rheonix, Inc. was founded in 2007 and is based in Ithaca, New York.

Business identity

Contact email
[email protected]
Phone number
(607)257-0979
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2007-01-01, Year

Headquarters

Postal code
14850
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
11
Total equity funding
$84.7M
Last funding
Convertible Note / 2019-02-13
Last equity funding
Series Unknown / $28.6M
Investors
6
Lead investors
2
Founders
1
Articles
13

Founders and investors

Founders

Gregory J. Galvin

Lead investors

Cayuga Venture FundRand Capital

Investors

Advantage CapitalCayuga Venture FundGefinor CapitalLimestone Capital AdvisorsRand Capital